SCHEMBL199724

SCHEMBL199724

CCO[Si](C)(C)C1CC2C=CC1C2

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6743756 0.86 KDM4E (0.31) KDM4EALDH1A1
SCHEMBL199719 0.86 KDM4E (0.33) KDM4EALDH1A1
SCHEMBL1070908 0.85 KDM4E (0.34) KDM4EALDH1A1
SCHEMBL29393800 0.83 KDM4E (0.35) KDM4EALDH1A1
SCHEMBL122625 0.83 KDM4E (0.35) KDM4EALDH1A1
SCHEMBL18949955 0.83 KDM4E (0.35) KDM4EALDH1A1
SCHEMBL202510 0.82 KDM4E (0.33) KDM4EALDH1A1
SCHEMBL5705805 0.81 KDM4E (0.34) KDM4EALDH1A1
SCHEMBL7113258 0.80 KDM4E (0.31) KDM4EALDH1A1
SCHEMBL4603482 0.80 KDM4E (0.33) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12629657-B2 Lithium ion adsorbents EMPOWER INNOVATION & TECHNOLOGY LLC (US) 2026-05-19 US claimed
CN-120202247-A Silane compound and composition containing same 昕特玛私人有限公司 2025-06-24 CN claimed
EP-4223409-A1 LITHIUM ION ADSORBENTS Conductive Energy Inc. (CA) 2023-08-09 EP claimed
US-20230241581-A1 LITHIUM ION ADSORBENTS CONDUCTIVE ENERGY INC. (CA) 2023-08-03 US claimed
EP-3197881-B1 DIAZIRINE COMPOUNDS AS PHOTOCROSSLINKERS AND PHOTOIMAGEABLE COMPOSITIONS COMPRISING THEM PROMERUS LLC (US) 2020-04-29 EP claimed
US-10303060-B2 Diazirine compounds and compositions derived therefrom PROMERUS, LLC (US) 2019-05-28 US claimed
US-20180186747-A1 DIAZIRINE COMPOUNDS AND COMPOSITIONS DERIVED THEREFROM PROMERUS, LLC (US) 2018-07-05 US claimed
US-9938241-B2 Diazirine compounds and compositions derived therefrom PROMERUS, LLC (US) 2018-04-10 US claimed
EP-3197881-A1 DIAZIRINE COMPOUNDS AS PHOTOCROSSLINKERS AND PHOTOIMAGEABLE COMPOSITIONS COMPRISING THEM Promerus, LLC (US) 2017-08-02 EP claimed
WO-2016049123-A1 DIAZIRINE COMPOUNDS AS PHOTOCROSSLINKERS AND PHOTOIMAGEABLE COMPOSITIONS COMPRISING THEM PROMERUS, LLC (US) 2016-03-31 WO claimed
US-20160083352-A1 DIAZIRINE COMPOUNDS AND COMPOSITIONS DERIVED THEREFROM SUMITOMO BAKELITE CO., LTD. (JP) 2016-03-24 US claimed
US-12629657-B2 Lithium ion adsorbents EMPOWER INNOVATION & TECHNOLOGY LLC (US) 2026-05-19 US disclosed
US-12590180-B2 Olefinic compositions comprising hydrocarbon resins ExxonMobil Product Solutions Company (US) 2026-03-31 US disclosed
EP-4619470-A1 SILANE COMPOUND AND COMPOSITIONS CONTAINING SAME Synthomer Sdn. Bhd. (MY) 2025-09-24 EP disclosed
CN-120202247-A Silane compound and composition containing same 昕特玛私人有限公司 2025-06-24 CN disclosed
EP-1223195-A2 Thermoplastic resin composition and shaped articles thereof JSR Corporation (JP) 2002-07-17 EP disclosed
US-20020042461-A1 Composition of cyclic olefin addition copolymer and cross-linked material JSR CORPORATION (JP) 2002-04-11 US disclosed
EP-1195397-A1 Composition of cyclic olefin addition copolymer and cross-linked material JSR Corporation (JP) 2002-04-10 EP disclosed
EP-0906588-B1 PHOTODEFINABLE DIELECTRIC COMPOSITIONS GOODRICH CO B F (US) 2002-03-27 EP disclosed
US-6121340-A MIXTURE CONTAINING PHOTOINITIATOR THE B. F. GOODRICH COMPANY (US) 2000-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590180-B2 Olefinic compositions comprising hydrocarbon resins RAD51, COG2, HRH2 KDM4E 2141/4885ALDH1A1 1408/4885
US-20160083352-A1 DIAZIRINE COMPOUNDS AND COMPOSITIONS DERIVED THEREFROM RDX, AOX1, ALDH1A2 KDM4E 2719/4885ALDH1A1 24/4885
US-12629657-B2 Lithium ion adsorbents ILK, SDC1, LAMTOR3 KDM4E 193/4885ALDH1A1 2379/4885
US-20180186747-A1 DIAZIRINE COMPOUNDS AND COMPOSITIONS DERIVED THEREFROM ZYX, AOX1, RDX KDM4E 1745/4885ALDH1A1 145/4885
US-10303060-B2 Diazirine compounds and compositions derived therefrom ZYX, AOX1, RDX KDM4E 1745/4885ALDH1A1 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.